DK0828486T3 - Anvendelse af pyrrolidinderivater til behandling af alkoholisme - Google Patents

Anvendelse af pyrrolidinderivater til behandling af alkoholisme

Info

Publication number
DK0828486T3
DK0828486T3 DK96918727T DK96918727T DK0828486T3 DK 0828486 T3 DK0828486 T3 DK 0828486T3 DK 96918727 T DK96918727 T DK 96918727T DK 96918727 T DK96918727 T DK 96918727T DK 0828486 T3 DK0828486 T3 DK 0828486T3
Authority
DK
Denmark
Prior art keywords
pct
pyrrolidine derivatives
treat alcoholism
sec
date
Prior art date
Application number
DK96918727T
Other languages
Danish (da)
English (en)
Inventor
Assunta Imperato
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0828486T3 publication Critical patent/DK0828486T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DK96918727T 1995-06-01 1996-05-29 Anvendelse af pyrrolidinderivater til behandling af alkoholisme DK0828486T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9506530A FR2734724B1 (fr) 1995-06-01 1995-06-01 Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'alcoolisme
PCT/FR1996/000801 WO1996038139A1 (fr) 1995-06-01 1996-05-29 Utilisation de derives de pyrrolidine au traitement de l'alcoolisme

Publications (1)

Publication Number Publication Date
DK0828486T3 true DK0828486T3 (da) 2003-01-27

Family

ID=9479586

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96918727T DK0828486T3 (da) 1995-06-01 1996-05-29 Anvendelse af pyrrolidinderivater til behandling af alkoholisme

Country Status (27)

Country Link
US (1) US5935980A (de)
EP (1) EP0828486B1 (de)
JP (1) JPH11511747A (de)
KR (1) KR100424997B1 (de)
CN (1) CN1186432A (de)
AT (1) ATE224190T1 (de)
AU (1) AU711625B2 (de)
BG (1) BG63189B1 (de)
BR (1) BR9608633A (de)
CA (1) CA2219455C (de)
CZ (1) CZ289344B6 (de)
DE (1) DE69623767T2 (de)
DK (1) DK0828486T3 (de)
EA (1) EA000722B1 (de)
ES (1) ES2182987T3 (de)
FR (1) FR2734724B1 (de)
GE (1) GEP19991780B (de)
HU (1) HUP9900748A3 (de)
IL (1) IL118491A (de)
NO (1) NO975488L (de)
NZ (1) NZ310488A (de)
PT (1) PT828486E (de)
RO (1) RO117297B1 (de)
SK (1) SK282063B6 (de)
UA (1) UA58492C2 (de)
WO (1) WO1996038139A1 (de)
ZA (1) ZA964270B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2744362B1 (fr) * 1996-02-07 1998-02-27 Rhone Poulenc Rorer Sa Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
FR2744361B1 (fr) * 1996-02-07 1998-02-27 Rhone Poulenc Rorer Sa Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
FR2744363B1 (fr) * 1996-02-07 1998-02-27 Rhone Poulenc Rorer Sa Application de derives de thiazolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
TW442449B (en) 1996-07-04 2001-06-23 Hoechst Ag Process for preparing 1,2-dichloroethane by direct chlorination
US6512120B1 (en) 2001-03-12 2003-01-28 Ortho Mcneil Pharmaceutical, Inc. Methods for the synthesis of densely functionalized pyrrolidine intermediates
US6869335B2 (en) 2002-07-08 2005-03-22 Micron Technology, Inc. Retaining rings, planarizing apparatuses including retaining rings, and methods for planarizing micro-device workpieces
US8247438B2 (en) 2008-02-27 2012-08-21 Neuropill, Inc. Methods for treating schizophrenia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678938B1 (fr) * 1991-07-10 1993-10-08 Rhone Poulenc Rorer Sa Derives de pyrrolidine, leur preparation et les medicaments les contenant.
GB9203790D0 (en) * 1992-02-21 1992-04-08 Merck Sharp & Dohme Therapeutic agents
FR2700166B1 (fr) * 1993-01-07 1995-02-17 Rhone Poulenc Rorer Sa Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.

Also Published As

Publication number Publication date
NO975488L (no) 1998-01-19
BG102087A (en) 1998-10-30
CZ378597A3 (cs) 1998-03-18
BR9608633A (pt) 1999-02-02
RO117297B1 (ro) 2002-01-30
MX9708875A (es) 1998-03-31
EP0828486A1 (de) 1998-03-18
ZA964270B (en) 1996-08-26
UA58492C2 (uk) 2003-08-15
IL118491A0 (en) 1996-09-12
BG63189B1 (bg) 2001-06-29
WO1996038139A1 (fr) 1996-12-05
ES2182987T3 (es) 2003-03-16
EA000722B1 (ru) 2000-02-28
SK161197A3 (en) 1998-05-06
JPH11511747A (ja) 1999-10-12
AU6129096A (en) 1996-12-18
CA2219455C (fr) 2009-02-24
SK282063B6 (sk) 2001-10-08
GEP19991780B (en) 1999-10-05
EA199700439A1 (ru) 1998-08-27
CA2219455A1 (fr) 1996-12-05
KR19990021859A (ko) 1999-03-25
CN1186432A (zh) 1998-07-01
US5935980A (en) 1999-08-10
FR2734724B1 (fr) 1997-07-04
FR2734724A1 (fr) 1996-12-06
AU711625B2 (en) 1999-10-21
NO975488D0 (no) 1997-11-28
EP0828486B1 (de) 2002-09-18
HUP9900748A1 (hu) 1999-07-28
ATE224190T1 (de) 2002-10-15
KR100424997B1 (ko) 2004-06-23
IL118491A (en) 2002-05-23
DE69623767T2 (de) 2003-07-03
PT828486E (pt) 2002-12-31
HUP9900748A3 (en) 2000-01-28
CZ289344B6 (cs) 2002-01-16
NZ310488A (en) 2000-07-28
DE69623767D1 (de) 2002-10-24

Similar Documents

Publication Publication Date Title
ATE326464T1 (de) Indazolyl-substituierte pyrrolidin-verbindungen als kinase inhibitoren
DK0971713T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser
DE69612003D1 (de) Substituierte benzolaktamverbindungen als substanz-p-antagonisten
DE69512797T2 (de) Prostaglandin-synthase hemmer
DK0840601T3 (da) THIP til behandling af søvnforstyrrelser
DK0828741T3 (da) Spirocykliske og bicykliske diazinyl- og carbazinyloxazolidinoner
DE69512930D1 (de) Stilben-derivate verwendbar als cyclooxygenase-2 hemmer
DK0828486T3 (da) Anvendelse af pyrrolidinderivater til behandling af alkoholisme
DE69808099T2 (de) Substituierte 6-alkylphenanthridine
WO2001091796A8 (en) Methods, compounds and compositions for treating gout
ATE179168T1 (de) Substituierte spiroverbindungen zur behandlung von entzündungen
DK0674521T3 (da) Fremgangsmåde til behandling af kronisk prostatitis med 17beta-N-tertbutylcarbamoyl-4-aza-5a-andost-1-en-3-on
EA199800931A1 (ru) Способ получения ингибиторов фосфодиэстеразы iv
ATE160782T1 (de) Fluoro-nukleosid-reinigung